by Evelyn Ma | Jan 26, 2026 | Blog
At Reaction Biology, quality is a commitment we can measure. We hold ourselves accountable for data integrity and report delivery metrics that define a quantifiable standard for our scientific operations. These performance metrics govern how we generate and deliver...
by Evelyn Ma | Jan 19, 2026 | Newsletter
Headlines In This Issue Featured Research: Preclinical Models Our novel approach maintains BBB integrity in preclinical brain tumor models, enabling more predictive assessment of CNS therapeutic penetration and efficacy. Scientific Spotlight: GPCRs and...
by Evelyn Ma | Oct 14, 2025 | Uncategorized
Headlines In This Issue Scientific Spotlight ADC featured research: Kadcyla vs. Enhertu comparative study with SPR data and insights on what’s driving ADC innovation in 2025 Important Dates See compound submission deadlines for multiple screening panels plus...
